Glyko gets grant for lysosomal storage diseases tests:
This article was originally published in Clinica
Executive Summary
Glyko Biomedical has been awarded a Phase II small business innovative research grant to develop a second-generation diagnostic test system for the group of inherited metabolic disorders called lysosomal storage diseases. The grant, from the National Institute of Child Health and Human Development, is just under $600,000 over two years. Glyko, based in Novato, California, estimates there are more than 35 lysosomal storage diseases, which affect over 30,000 people in the US.